|
|
Volumn 17, Issue 1, 1996, Pages 9-18
|
|
Platelet glycoprotein IIb/IIIa receptor antagonists in coronary artery disease
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLCYSTEINYLASPARAGINYL 5,5 DIMETHYLTHIOPROLYL 4 AMINOMETHYLPHENYLALANYLGLYCYLASPARTYLCYSTEINE;
ACETYLSALICYLIC ACID;
ANTITHROMBOCYTIC AGENT;
CYCLO(DEXTRO 2 AMINOBUTYRYL 2 N METHYLARGINYLGLYCYLASPARTYL 3 AMINOMETHYLBENZOIC ACID) METHANESULFONATE;
EPTIFIBATIDE;
FIBRINOGEN RECEPTOR;
FIBRINOGEN RECEPTOR ANTAGONIST;
LAMIFIBAN;
N ACETYLCYSTEINYLASPARAGINYLPROLYLARGINYLGLYCYLASPARTYL(O METHYLTYROSYL)ARGINYLCYSTEINAMIDE CYCLIC 1,9 DISULFIDE;
TIROFIBAN;
UNCLASSIFIED DRUG;
ACUTE HEART INFARCTION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY DISEASE;
DRUG EFFICACY;
HUMAN;
META ANALYSIS;
PRIORITY JOURNAL;
REVIEW;
THROMBOCYTE AGGREGATION INHIBITION;
THROMBOCYTE FUNCTION;
UNSTABLE ANGINA PECTORIS;
|
|
EID: 0029879229
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: 10.1093/oxfordjournals.eurheartj.a014698 Document Type: Review |
|
Times cited : (73)
|
|
References (0)
|
